Radiation therapy with chemotherapy for patients with cervical cancer and supraclavicular lymph node involvement (vol 23, pg 159, 2012)
- Authors
- 이석호; 이승헌; 이규찬; 이광범; 신진우; 박찬용; 심선진; 이준호
- Issue Date
- Oct-2012
- Publisher
- 대한부인종양학회
- Keywords
- Cervical cancer; Chemotherapy; Radiation therapy; Supraclavicular lymph node
- Citation
- Journal of Gynecologic Oncology, v.23, no.4, pp.293 - 293
- Journal Title
- Journal of Gynecologic Oncology
- Volume
- 23
- Number
- 4
- Start Page
- 293
- End Page
- 293
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/80655
- DOI
- 10.3802/jgo.2012.23.4.293
- ISSN
- 2005-0380
- Abstract
- Objective: We wanted to evaluate the outcomes of cervical cancer patients with supraclavicular lymph node (SCLN) involvement and who received radiation therapy (RT) combined with chemotherapy.
Methods: From April 2001 to April 2009, seven cervical cancer patients with SCLN involvement were treated by RT and cisplatin-based chemotherapy. All of the patients also had a positive para-aortic lymph node(s) (PALNs). The RT field was designed to include the whole pelvis, the involved PALNs and the SCLN area. The median SCLN RT dose was 66.6 Gy (range, 60 to 75.6 Gy).
Results: The median follow-up period was 79 months (range, 13 to 98 months). The 3-year and 5-year overall survival rates were 57.1% and 57.1%, respectively and the 3- and 5-year disease-free survival rates were 57.1% and 42.9%, respectively. The acute hematologic toxicities according to the criteria of Radiation Therapy Oncology Group (RTOG) were G1/2 leukopenia in 2 (29%), G3/4 leukopenia in 5 (71%), G1/2 anemia in 6 (86%), G3 anemia in 1 (14%), G2 thrombocytopenia in 1 (14%) and G3/4 thrombocytopenia in 2 (29%). Within 6 months after RT, most of the patients (4/5; 80%) recovered from the G3/4 leukopenia, except for 1 patient who received chemotherapy after completing RT due to subsequent bone metastasis.
Conclusion: RT with chemotherapy as active therapy can be expected to provide favorable results for appropriately selected cervical cancer patients with SCLN involvement but no evidence of distant metastasis. The well designed study enrolling more patients will be necessary to clarify the future indications and selection criteria.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/80655)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.